Antibiotic-resistant infections and deaths increased by 15% during the pandemic, according to the Infectious Diseases Society of America (IDSA).
Luckily, clinicians have quite a few newer antibiotic options for treating resistant pneumonias, and these new options are sorely needed, according to Thomas M. File, MD, the chair of the Infectious Disease Division and co-director of the Antimicrobial Stewardship Program at Summa Health, in Akron, Ohio, and a past president of the